Thermo Fisher Scientific: Q4 Earnings Insights
Portfolio Pulse from Benzinga Insights
Thermo Fisher Scientific (NYSE:TMO) reported Q4 earnings with an EPS of $5.67, slightly beating the estimate of $5.64 by 0.53%. However, revenue decreased by $564 million compared to the same period last year. In the previous quarter, a beat on EPS resulted in a 1.61% share price increase the following day. The company's past earnings performance shows mixed results with both beats and matches on EPS estimates.
January 31, 2024 | 11:05 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Thermo Fisher Scientific reported a slight beat on Q4 EPS estimates but saw a decrease in revenue compared to last year. Historical data suggests a potential positive impact on share price following an earnings beat.
Thermo Fisher's EPS beat, albeit small, could be seen positively by investors, potentially leading to a short-term increase in stock price, similar to the 1.61% rise after last quarter's earnings beat. However, the decrease in revenue may temper investor enthusiasm, making the overall impact less predictable.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100